![Klaus Lücke](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Klaus Lücke is the founder of GILUPI GmbH, which was founded in 2006.
He held the title of Chief Executive Officer from 2009 to 2012.
Dr. Lücke also worked as an Executive Director at Infineon Technologies AG, a Development Manager at Siemens AG, and a Principal at Bell Laboratories.
Dr. Lücke received his undergraduate degree from Freie Universität Berlin.
| Unternehmen | Position | Ende |
|---|---|---|
| INFINEON TECHNOLOGIES AG | Direktor/Vorstandsmitglied | - |
| SIEMENS AG | Corporate Officer/Principal | - |
Bell Laboratories
 Bell Laboratories Miscellaneous Commercial ServicesCommercial Services Provides research and development services | Corporate Officer/Principal | - |
GILUPI GmbH
 GILUPI GmbH Medical SpecialtiesHealth Technology Engages in the development and production of products for the in-vivo isolation of rare cells from the circulation | Vorstandsvorsitzender | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
| Private Unternehmen | 5 |
|---|---|
Siemens AG
 Siemens AG Industrial MachineryProducer Manufacturing Develops, manufactures and sells diagnostic and therapeutic products & automation systems | Producer Manufacturing |
Infineon Technologies AG
 Infineon Technologies AG SemiconductorsElectronic Technology Provides semiconductor solutions | Electronic Technology |
Bell Laboratories
Bell Laboratories Miscellaneous Commercial ServicesCommercial Services Provides research and development services | Commercial Services |
Freie Universität Berlin
 Freie Universität Berlin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
GILUPI GmbH
GILUPI GmbH Medical SpecialtiesHealth Technology Engages in the development and production of products for the in-vivo isolation of rare cells from the circulation | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen
